|
|
|

| Test Code |
Procedure |
| 500330 |
Vanillylmandelic Acid (VMA), Urine (Includes Creatinine) |
| 300914 |
Venous Occlusion Evaluation
(Plasminogen Activator Inhibitor - 1 Activity - Pre-occlusion, Tissue Plasminogen Activator Antigen - Pre-occlusion, Tissue Plasminogen Activator Antigen - Post-occlusion) |
| 300903 |
Venous Thrombosis (Hypercoagulability) Evaluation for Patients on VKA (Vitamin K Antagonist) Therapy (APTT, Immediate APTT Mixing Studies, Activated Protein C Resistance, Factor V Leiden Mutation, Anticardiolipin Antibody (IgG, IgM), Antithrombin Activity, Factor II Gene Mutation (Prothrombin G20210A), dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Antigen, Protein S Antigen Total, Factor VII Antigen*RUO*, Factor VIII Activity, Protein C Antigen/Factor VII Antigen Ratio*RUO*, Protein S Antigen/Factor VII Antigen Ratio*RUO*, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 300901 |
Venous Thrombosis (Hypercoagulability) Profile (APTT, Immediate APTT Mixing Studies, Activated Protein C Resistance, Factor V Leiden Mutation, Anticardiolipin Antibody (IgG, IgM), Antithrombin Activity, Factor II Gene Mutation (Prothrombin G20210A), dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Activity (Chromogenic), Protein S Antigen Free, Factor VIII Activity, beta-2 Glycoprotein I IgG, IgA, IgM, Lupus Anticoagulant Interpretation) |
| 500334 |
Vitamin B-12 |
| 500342 |
Vitamin D, 1, 25-Dihydroxy |
| 500337 |
Vitamin D, 25-Hydroxy, Fractionated, Mass Spectrometry |
| 500338 |
Vitamin D, 25-Hydroxy, Total, Mass Spectrometry |
| 300910 |
von Willebrand Disease Evaluation
(APTT, Collagen Binding Ratio, von Willebrand Factor Collagen Binding Activity, Factor VIII Activity, von Willebrand Factor Activity, von Willebrand Factor Antigen) |
| 300114 |
von Willebrand Factor Activity
(Ristocetin Cofactor) |
| 300113 |
von Willebrand Factor Antigen
(Factor VIII Related Antigen) |
| 300117 |
von Willebrand Factor Multimers |
| 300115 |
von Willebrand Factor Type 2 N Binding*** |
| 300919 |
von Willebrand Inhibitor Profile
(Factor VIII Activity, von Willebrand Factor Antigen, von Willebrand Factor Activity, von Willebrand Activity NP Control, von Willebrand Activity 1:1 NP Mixing Study, von Willebrand Collagen Binding Activity, Collagen Binding ratio, Pathologist interpretation) |
| 304910 |
von Willebrand Screening Profile (APTT, Factor VIII Activity, von Willebrand Factor Activity, von Willebrand Factor Antigen) |
|
|
|

 |
|
 |